gaboxadol has been researched along with Anochlesia in 1 studies
gaboxadol: GABA agonist; inhibitor of GABA uptake systems; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect on catalepsy was the most pronounced." | 1.26 | Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics. ( Arnt, J; Christensen, AV, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnt, J | 1 |
| Christensen, AV | 1 |
1 other study available for gaboxadol and Anochlesia
| Article | Year |
|---|---|
Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics.
Topics: Amphetamine; Animals; Antipsychotic Agents; Catalepsy; Humans; Isoxazoles; Male; Oxazoles; Rats; Sco | 1981 |